BIOCRYST PHARMACEUTICALS INC (BCRX) › Shareholders' EquityBIOCRYST PHARMACEUTICALS INC (BCRX) — Shareholders' EquityAnnual figures by period end, from SEC filings.2008-12-31: $46.43M2009-12-31: $86.27M2010-12-31: $65.50M2011-12-31: $14.81M2012-12-31: -$454.0K2013-12-31: -$1.13M2014-12-31: $75.64M2015-12-31: $47.72M2016-12-31: $1.58M2017-12-31: $83.77M2018-12-31: $49.23M2019-12-31: $38.25M2020-12-31: -$19.26M2021-12-31: -$106.99M2022-12-31: -$294.60M2023-12-31: -$455.53M2024-12-31: -$475.93M2025-12-31: -$119.15M-$119.15M2008-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31-$119.15M—2026-02-26Balance as of period end2024-12-31-$475.93M—2026-02-26Balance as of period end2023-12-31-$455.53M—2026-02-26Balance as of period end2022-12-31-$294.60M—2026-02-26Balance as of period end2021-12-31-$106.99M—2025-02-25Balance as of period end2020-12-31-$19.26M-150.4%2024-02-27Balance as of period end2019-12-31$38.25M-22.3%2023-02-27Balance as of period end2018-12-31$49.23M-41.2%2022-02-28Balance as of period end2017-12-31$83.77M+5208.4%2021-03-01Balance as of period end2016-12-31$1.58M-96.7%2020-03-13Balance as of period end2015-12-31$47.72M-36.9%2019-03-14Balance as of period end2014-12-31$75.64M—2018-03-12Balance as of period end2013-12-31-$1.13M—2017-02-27Balance as of period end2012-12-31-$454.0K-103.1%2016-02-26Balance as of period end2011-12-31$14.81M-77.4%2015-03-02Balance as of period end2010-12-31$65.50M-24.1%2014-03-10Balance as of period end2009-12-31$86.27M+85.8%2013-03-11Balance as of period end2008-12-31$46.43M—2012-03-06Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)